How much dividend does SenzaGen pay?
Over the past 12 months, SenzaGen paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, SenzaGen is expected to pay a dividend of 0 SEK.
SenzaGen Dividend 2024
SenzaGen Dividend
0 SEK
SenzaGen Dividend yield
Ticker
SENZA.ST
ISIN
SE0010219626
WKN
A2DX79
How much dividend does SenzaGen 2024 pay?
According to the latest status from November 2024, SenzaGen paid a total of 0 SEK per share in dividends within the last 12 months. With the current SenzaGen price of 7.35 SEK, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.
| = |
Historical SenzaGen Dividends
A dividend is paid times per year. Last year, the payout months were and .
| Paydate | Dividend |
|---|
Is the SenzaGen Dividend Safe?
SenzaGen has been increasing the dividend for 0 years.
Over the past 10 years, SenzaGen has increased it by an annual 0 %.
Over a five-year period, the distribution increased by 0%.
Analysts expect a Dividend Cut of -100% for the current fiscal year.
Dividend Details
Understanding SenzaGen's Dividend Distributions
SenzaGen’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining SenzaGen's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
SenzaGen's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in SenzaGen’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
SenzaGen Aktienanalyse
What does SenzaGen do?
SenzaGen AB is a Swedish biotechnology company that specializes in the development and marketing of innovative and reliable tests for assessing allergenicity. Founded in 2010 by leading experts from the academic and industry sectors, the company has become a significant player in the field of toxicology. Current methods for assessing allergenicity, such as asthma, eczema, and allergic reactions, are often inaccurate and require the use of animals, which is ethically questionable and expensive. SenzaGen AB has developed a wide range of tests based on biomolecular technologies that use human cells to assess the allergenic reactivity of chemicals and products. These tests are accurate, cost-effective, and meet the current requirements of regulatory authorities and the industry. The company is headquartered in Lund, Sweden, and currently employs about 20 people. SenzaGen AB is a leader in the development of in vitro methods for evaluating allergenicity and utilizes various platform technologies such as gene expression and proteomics analysis, as well as the use of immune cells and keratinocytes. SenzaGen AB's Microarray technology platform, based on DNA-based tests, has been recognized by the European Chemicals Agency (ECHA) as suitable for assessing allergenic reactivity. The company has also partnered with the US biotechnology company In vitro International (IVI) to distribute its allergen tests in the North American market. SenzaGen AB has developed a wide range of products that can be used in various sectors such as cosmetics, food, chemicals, and pharmaceuticals. AllergoDx™ is a test system used by the pharmaceutical and chemical industries to determine the allergenic reactivity of chemicals. GARD™ (Genomic Allergen Rapid Detection) is a rapid test used in the cosmetics and food industries to determine the allergenic reactivity of new products and avoid costly animal testing. GARDskin™ is a skin test used to determine the reactivity of substances that come into contact with the skin, primarily in the chemicals and pharmaceutical industries. Other products in the company's pipeline include GARDpotency™ and GARDair™, which are intended for assessing allergic reactions in industrial and occupational environments. SenzaGen AB has experienced significant growth in recent years and plans to expand its product range and strengthen its market position. The company's business model is based on selling tests and services to chemical, pharmaceutical, food, and cosmetic companies worldwide. Through its innovative technologies and willingness to collaborate with customers, the company has taken a leadership role in toxicology. SenzaGen AB is committed to an ethical and responsible corporate philosophy focused on sustainability and environmental protection. The company has clear goals to meet the growing demand for reliable and ethical testing methods to minimize the impact of chemicals on humans and the environment. SenzaGen is one of the most popular companies on Eulerpool.com.Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Frequently Asked Questions about SenzaGen stock
What is the dividend yield of SenzaGen?
The current dividend yield of SenzaGen is .
When does SenzaGen pay dividends?
SenzaGen pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of SenzaGen?
SenzaGen paid dividends every year for the past 0 years.
What is the dividend of SenzaGen?
For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.
In which sector is SenzaGen located?
SenzaGen is assigned to the 'Health' sector.
Wann musste ich die Aktien von SenzaGen kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of SenzaGen from 11/5/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 11/5/2024.
When did SenzaGen pay the last dividend?
The last dividend was paid out on 11/5/2024.
What was the dividend of SenzaGen in the year 2023?
In the year 2023, SenzaGen distributed 0 SEK as dividends.
In which currency does SenzaGen pay out the dividend?
The dividends of SenzaGen are distributed in SEK.
Andere Kennzahlen von SenzaGen
Our stock analysis for SenzaGen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SenzaGen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
